A customized long acting formulation of the kisspeptin analog C6 triggers ovulation in anestrus ewe.


Journal

Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461

Informations de publication

Date de publication:
04 2022
Historique:
revised: 07 03 2022
received: 08 12 2021
accepted: 10 03 2022
pubmed: 1 4 2022
medline: 28 4 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

The modulation of the kisspeptin system holds promise as a treatment for human reproductive disorders and for managing livestock breeding. The design of analogs has overcome some unfavorable properties of the endogenous ligands. However, for applications requiring a prolongation of drug activity, such as ovulation induction in the ewe during the non-breeding season, additional improvement is required. To this aim, we designed and tested three formulations containing the kisspeptin analog C6. Two were based on polymeric nanoparticles (NP1 and NP2) and the third was based on hydrogels composed of a mixture of cyclodextrin polymers and dextran grafted with alkyl side chains (MD/pCD). Only the MD/pCD formulation prolonged C6 activity, as shown by monitoring luteinizing hormone (LH) plasma concentration (elevation duration 23.4 ± 6.1, 13.7 ± 4.7 and 12.0 ± 2.4 h for MD/pCD, NP1 and NP2, respectively). When compared with the free C6 (15 nmol/ewe), the formulated (MD/pCD) doses of 10, 15 and 30 nmol/ewe, but not the 90 nmol/ewe dose, provided a more gradual release of C6 as shown by an attenuated LH release during the first 6 h post-treatment. When tested during the non-breeding season without progestogen priming, only, the formulated 30 nmol/ewe dose triggered ovulation (50% of ewes). Hence, we showed that a formulation with an adapted action time would improve the efficacy of C6 with respect to inducing ovulation during the non-breeding season. This result suggests that formulations containing a kisspeptin analog might find applications in the management of livestock reproduction but also point to the possibility of their use for the treatment of some human reproductive pathologies.

Identifiants

pubmed: 35355344
doi: 10.1111/jne.13121
doi:

Substances chimiques

Kisspeptins 0
Luteinizing Hormone 9002-67-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13121

Informations de copyright

© 2022 British Society for Neuroendocrinology.

Références

Beltramo M, Decourt C. Towards new strategies to manage livestock reproduction using kisspeptin analogs. Theriogenology. 2018;112:2-10. doi:10.1016/j.theriogenology.2017.08.026
Abbara A, Clarke SA, Dhillo WS. Clinical potential of Kisspeptin in reproductive health. Trends Mol Med. 2021;27(8):807-823. doi:10.1016/j.molmed.2021.05.008
Beltramo M, Robert V, Galibert M, et al. Rational design of triazololipopeptides analogs of kisspeptin inducing a long-lasting increase of gonadotropins. J Med Chem. 2015;58(8):3459-3470. doi:10.1021/jm5019675
Decourt C, Robert V, Anger K, et al. A synthetic kisspeptin analog that triggers ovulation and advances puberty. Sci Rep. 2016;6:26908. doi:10.1038/srep26908
Messager S, Chatzidaki EE, Ma D, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA. 2005;102(5):1761-1766.
Han SK, Gottsch ML, Lee KJ, et al. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci. 2005;25(49):11349-11356.
Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614-1627.
de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972-10976.
Hashizume T, Saito H, Sawada T, et al. Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats. Anim Reprod Sci. 2010;118(1):37-41.
Whitlock BK, Daniel JA, Wilborn RR, et al. Interaction of estrogen and progesterone on kisspeptin-10-stimulated luteinizing hormone and growth hormone in ovariectomized cows. Neuroendocrinology. 2008;88(3):212-215.
Leonardi CEP, Dias FCF, Adams GP, Singh J. Effect of Kisspeptin-10 on plasma luteinizing hormone concentrations and follicular dynamics during the luteal phase in cattle. Theriogenology. 2018;119:268-274. doi:10.1016/j.theriogenology.2018.06.023
Magee C, Foradori CD, Bruemmer JE, et al. Biological and anatomical evidence for kisspeptin regulation of the hypothalamic-pituitary-gonadal axis of estrous horse mares. Endocrinology. 2009;150(6):2813-2821.
Decourt C, Caraty A, Briant C, et al. Acute injection and chronic perfusion of kisspeptin elicit gonadotropins release but fail to trigger ovulation in the mare. Biol Reprod. 2014;90(2):36. doi:10.1095/biolreprod.113.114157
Navarro VM, Fernandez-Fernandez R, Castellano JM, et al. Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J Physiol. 2004;561(Pt 2):379-386.
Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA. 2005;102(6):2129-2134.
Albers-Wolthers KH, de Gier J, Kooistra HS, et al. Identification of a novel kisspeptin with high gonadotrophin stimulatory activity in the dog. Neuroendocrinology. 2014;99(3-4):178-189.
Caraty A, Smith JT, Lomet D, et al. Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes. Endocrinology. 2007;148(11):5258-5267.
Sebert ME, Lomet D, Said SB, et al. Insights into the mechanism by which kisspeptin stimulates a preovulatory LH surge and ovulation in seasonally acyclic ewes: potential role of estradiol. Domest Anim Endocrinol. 2010;38(4):289-298.
Decourt C, Robert V, Lomet D, et al. The kisspeptin analog C6 is a possible alternative to PMSG (pregnant mare serum gonadotropin) for triggering synchronized and fertile ovulations in the alpine goat. PLoS One. 2019;14(3):e0214424. doi:10.1371/journal.pone.0214424
Asami T, Nishizawa N, Matsui H, et al. Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. J Med Chem. 2013;56(21):8298-8307. doi:10.1021/jm401056w
Goto Y, Endo N, Nagai K, et al. Ovarian and hormonal responses to follicular phase administration of investigational metastin/kisspeptin analog, TAK-683, in goats. Reprod Domest Anim. 2014;49(2):338-342.
Essa D, Kondiah PPD, Choonara YE, Pillay V. The Design of Poly(lactide-co-glycolide) Nanocarriers for medical applications. Front Bioeng Biotechnol. 2020;8:48. doi:10.3389/fbioe.2020.00048
Elmowafy EM, Tiboni M, Soliman ME. Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig. 2019;49:347-380. doi:10.1007/s40005-019-00439-x
Daoud-Mahammed S, Grossiord JL, Bergua T, Amiel C, Couvreur P, Gref R. Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs. J Biomed Mater Res A. 2008;86(3):736-748. doi:10.1002/jbm.a.31674
Daoud-Mahammed S, Ringard-Lefebvre C, Razzouq N, et al. Spontaneous association of hydrophobized dextran and poly-beta-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug. J Colloid Interface Sci. 2007;307(1):83-93. doi:10.1016/j.jcis.2006.10.072
Gref R, Amiel C, Molinard K, et al. New self-assembled nanogels based on host-guest interactions: characterization and drug loading. J Control Release. 2006;111(3):316-324. doi:10.1016/j.jconrel.2005.12.025
Daoud-Mahammed S, Couvreur P, Bouchemal K, et al. Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen. Biomacromolecules. 2009;10(3):547-554. doi:10.1021/bm801206f
Renard E, Deratani A, Volet G, Sebille B. Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers. Eur Polym J. 1997;33(1):49-57. doi:10.1016/S0014-3057(96)00123-1
Pelletier J, Kann G, Dolais J, Rosselin G. Radio-immunologic determination of plasma lutenizing hormone in sheep. Comparison with the biologic determination of LH by the diminution of ovarian ascorbic acid, and example of the application to measure of the blood LH in ewes. C R Acad Sci Hebd Seances Acad Sci D. 1968;266(25):2352-2354.
Montgomery GW, Martin GB, Pelletier J. Changes in pulsatile LH secretion after ovariectomy in Ile-de-France ewes in two seasons. J Reprod Fertil. 1985;73(1):173-183.
Leonardi CEP, Dias FCF, Adams GP, Araujo ER, Singh J. Kisspeptin induces ovulation in heifers under low plasma progesterone concentrations. Theriogenology. 2020;141:26-34. doi:10.1016/j.theriogenology.2019.08.033
Kanai N, Endo N, Ohkura S, et al. An administration of TAK-683 at a minimally effective dose for luteinizing hormone stimulation under the absence of the ovary induces luteinizing hormone surge in ovary-intact goats. J Reprod Dev. 2017;63(3):305-310. doi:10.1262/jrd.2016-184
McNatty KP, Gibb M, Dobson C, Thurley DC. Evidence that changes in luteinizing hormone secretion regulate the growth of the preovulatory follicle in the ewe. J Endocrinol. 1981;90(3):375-389. doi:10.1677/joe.0.0900375
Park K, Otte A, Sharifi F, et al. Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles. J Control Release. 2021;329:1150-1161. doi:10.1016/j.jconrel.2020.10.044
Noel B, Bister JL, Paquay R. Ovarian follicular dynamics in Suffolk ewes at different periods of the year. J Reprod Fertil. 1993;99(2):695-700. doi:10.1530/jrf.0.0990695
Monniaux D, Huet C, Besnard N, et al. Follicular growth and ovarian dynamics in mammals. J Reprod Fertil Suppl. 1997;51:3-23.
Freret S, Fatet A, Boyer L, Pantel C, Bodin L. Comparison of fertility after AI in 2 meat sheep breeds: Lacaune and blanche du massif central. 16èmes Rencontres-Rsecherches-Ruminants. 2008;16:305-308.
Ungerfeld R, Clemente N, Bonjour L, Orihuela A. Equine chorionic gonadotrophin administration to rams improves their effectiveness to stimulate anoestrous ewes (the "ram effect"). Anim Reprod Sci. 2014;149(3-4):194-198. doi:10.1016/j.anireprosci.2014.07.004
Dardente H, Lomet D, Robert V, Decourt C, Beltramo M, Pellicer-Rubio MT. Seasonal breeding in mammals: from basic science to applications and back. Theriogenology. 2016;86(1):324-332. doi:10.1016/j.theriogenology.2016.04.045
Chanvallon A, Sagot L, Pottier E, et al. New insights into the influence of breed and time of the year on the response of ewes to the 'ram effect'. Animal. 2011;5(10):1594-1604.
Jayasena CN, Nijher GM, Abbara A, et al. Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea. Clin Pharmacol Ther. 2010;88(6):840-847.
Jayasena CN, Abbara A, Veldhuis JD, et al. Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54. J Clin Endocrinol Metab. 2014;99(6):E953-E961.

Auteurs

Giuseppina Salzano (G)

Institut des Sciences Moléculaires d'Orsay (CNRS UMR 8214), Université Paris Saclay, Orsay, France.

Vincent Robert (V)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Didier Lomet (D)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Caroline Decourt (C)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Elise Hommet (E)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Flavie Derouin-Tochon (F)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Vincent Hellier (V)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Farah Savina (F)

Institut des Sciences Moléculaires d'Orsay (CNRS UMR 8214), Université Paris Saclay, Orsay, France.

Thimmalapura-Marulappa Vishwanatha (TM)

Centre de Biophysique Moléculaire (CNRS UPR 4301), Orléans, France.

Vincent Aucagne (V)

Centre de Biophysique Moléculaire (CNRS UPR 4301), Orléans, France.

Ruxandra Gref (R)

Institut des Sciences Moléculaires d'Orsay (CNRS UMR 8214), Université Paris Saclay, Orsay, France.

Massimiliano Beltramo (M)

Physiologie de la Reproduction et des Comportements (PRC) UMR7247 CNRS, IFCE, INRAE, Université de Tours, Nouzilly, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH